Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol).
Onsea J, Uyttebroek S, Chen B, Wagemans J, Lood C, Van Gerven L, Spriet I, Devolder D, Debaveye Y, Depypere M, Dupont L, De Munter P, Peetermans WE, van Noort V, Merabishvili M, Pirnay JP, Lavigne R, Metsemakers WJ. Onsea J, et al. Among authors: pirnay jp. Viruses. 2021 Aug 5;13(8):1543. doi: 10.3390/v13081543. Viruses. 2021. PMID: 34452408 Free PMC article.
Survey of Pseudomonas aeruginosa and its phages: de novo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses.
Ceyssens PJ, Noben JP, Ackermann HW, Verhaegen J, De Vos D, Pirnay JP, Merabishvili M, Vaneechoutte M, Chibeu A, Volckaert G, Lavigne R. Ceyssens PJ, et al. Among authors: pirnay jp. Environ Microbiol. 2009 May;11(5):1303-13. doi: 10.1111/j.1462-2920.2008.01862.x. Epub 2009 Feb 4. Environ Microbiol. 2009. PMID: 19207572
The phage therapy paradigm: prêt-à-porter or sur-mesure?
Pirnay JP, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, Zizi M, Laire G, Lavigne R, Huys I, Van den Mooter G, Buckling A, Debarbieux L, Pouillot F, Azeredo J, Kutter E, Dublanchet A, Górski A, Adamia R. Pirnay JP, et al. Pharm Res. 2011 Apr;28(4):934-7. doi: 10.1007/s11095-010-0313-5. Epub 2010 Nov 10. Pharm Res. 2011. PMID: 21063753 No abstract available.
Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany.
Merabishvili M, De Vos D, Verbeken G, Kropinski AM, Vandenheuvel D, Lavigne R, Wattiau P, Mast J, Ragimbeau C, Mossong J, Scheres J, Chanishvili N, Vaneechoutte M, Pirnay JP. Merabishvili M, et al. Among authors: pirnay jp. PLoS One. 2012;7(12):e52709. doi: 10.1371/journal.pone.0052709. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23285164 Free PMC article.
Call for a dedicated European legal framework for bacteriophage therapy.
Verbeken G, Pirnay JP, Lavigne R, Jennes S, De Vos D, Casteels M, Huys I. Verbeken G, et al. Among authors: pirnay jp. Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):117-29. doi: 10.1007/s00005-014-0269-y. Epub 2014 Feb 6. Arch Immunol Ther Exp (Warsz). 2014. PMID: 24500660 Free PMC article. Review.
129 results